SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 29, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-23-019380.pdf 0001558370-23-019380.rtf 0001558370-23-019380.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 18, 2024	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-24-000365.pdf 0001558370-24-000365.rtf 0001558370-24-000365.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 26, 2024	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-24-001707.pdf 0001558370-24-001707.rtf 0001558370-24-001707.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 04, 2024	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-24-004700.pdf 0001558370-24-004700.rtf 0001558370-24-004700.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 10, 2024	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-24-004898.pdf 0001558370-24-004898.rtf 0001558370-24-004898.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Apr 10, 2024	Report of unscheduled material events or corporate event	8-K	View HTML 0001558370-24-004933.pdf 0001558370-24-004933.rtf 0001558370-24-004933.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 10, 2009	Amendment to a previously filed 8-K	8-K/A	View HTML 0001193125-09-022996.pdf 0001193125-09-022996.rtf 0001193125-09-022996.xls
Jul 10, 2017	Amendment to a previously filed 8-K	8-K/A	View HTML 0001104659-17-044258.pdf 0001104659-17-044258.rtf 0001104659-17-044258.xls
Aug 01, 2017	Amendment to a previously filed 8-K	8-K/A	View HTML 0001104659-17-048454.pdf 0001104659-17-048454.rtf 0001104659-17-048454.xls
Dec 15, 2017	Amendment to a previously filed 8-K	8-K/A	View HTML 0001104659-17-073617.pdf 0001104659-17-073617.rtf 0001104659-17-073617.xls

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE